MIST1 is a transcription factor expressed in pancreatic acinar cells and other serous exocrine cells.
Introduction
MIST1 is a transcription factor belonging to the class B family of basic helix-loop-helix (bHLH) proteins [1] . Class B bHLH proteins typically exhibit tissue specific expression and affect transcription of genes involved in cell determination, differentiation and cellular functions. Mist1 (also referred to as Basic helix loop helix a15; Bhlha15, or dimmed in Drosophila) is expressed in all serous type exocrine cells including pancreatic and salivary acini, Chief cells of the stomach, and secretory cells of the seminal vesicle, prostate and lactating mammary gland [2] . All MIST1 expressing cells rely on regulated exocytosis for their primary function. During regulated exocytosis, Ca 2+ is tightly controlled with release into and uptake from the cytosol being regulated by proteins that act as ion channels and pumps, respectively [3, 4] . Upon secretagogue stimulation, Mist1 −/− pancreatic acini exhibit a rapid release of Ca 2+ into the cytosol but clearance of Ca 2+ from the cytosol does not occur, leading to sustained high levels of cytosolic Ca 2+ within Mist1 −/− acinar cells [5] . -ATPases (PMCAs) and secretory pathway Ca 2+ -ATPases (SPCAs) [6] [7] [8] . These pumps either move activator Ca 2+ out of the cell (PMCAs) or move Ca 2+ from the cytosol back into Ca 2+ stores such as the ER (SERCAs) and Golgi (SPCAs) [9] .
Previous studies indicated no change in the total expression levels of SERCA and PMCA proteins in Mist1 −/− acini cultures but the SPCA proteins were not examined [5] .
In this study, we examined expression of the Atp2a, -b, -c gene family in wild type (WT) and Mist1 −/− mice. In Mist1 single dose of tamoxifen (4 mg/mouse) or control corn oil as previously described [11] . All mice were provided with a standard diet and water ad libidum.
RNA isolation and quantification
All reagents were from Promega (Ottawa, ON) unless otherwise stated. RNA was isolated from the pancreas as described [12] or from whole tissues, primary acinar cell cultures, or AR42J and ARIP cell lines using Trizol (Invitrogen, Burlington, ON) as per manufacturer's protocol. Alternatively, pancreas RNA was isolated at 24 h, 48 h, and 72 h post-tamoxifen treatment of Mist1 CreER/CreER /LSL-Mist1 myc mice using the RNeasy isolation system (QIAGEN, Valencia, CA) and reverse transcribed using the iScript™ cDNA synthesis kit (Bio-Rad, Hercules, CA). For RT-PCR, 1 μg of total RNA was reversed transcribed using random primers and Improm II reverse transcriptase, then amplified through 35 rounds of denaturing (94°C for 30 s), annealing (60-68°C for 40 s), and elongation (72°C for 60 s). For primer sequences and conditions see Table S1 . All primers were designed using sequences from the National Center for Biotechnology Information web database (www.ncbi.nlm.nih. gov) and generated by Sigma-Genosys (Oakville, ON). Quantitative (q) RT-PCR was performed using the Roche LightCycler® 2.0 System (Roche, Mannheim, Germany) with the LightCycler® FastStart DNA Master PLUS SYBR Green I kit. The amplification process consisted of an initial denaturation step (95°C for 10 m), a reaction cycle (95°C for 10 s), annealing (59.9-68.1°C for 5 s), and elongation (72°C for 10 s). For primer sequences and conditions see Table S1 . Northern blot analysis was performed as described [12] . Blots were hybridized overnight at 42°C with α 32 P-dCTP-radiolabeled probe (1 × 10 6 cpm/ml). The template for the probe was made from DNA plasmids containing the Atp2c2 sequence. 
SPCA2 antibody generation and protein analysis
In collaboration with ProSci Inc. (Poway, CA), a peptide sequence for antibody production was determined using the sequence of the carboxy-terminal domain of the mouse SPCA2 (NCBI Accession #ABS18966). The optimal antigenic site was determined to be KLWEKFLSRARPTQMLPEAV. Protein was isolated and western blot analysis was performed as described [13] . 10-50 μg of protein was resolved by SDS-PAGE and transferred to PVDF membrane (BioRad, Hercules, CA). The rabbit anti-SPCA2 (1:3000) and anti-β-tubulin (1:500, Santa Cruz) were recognized by HRP-conjugated goat anti-rabbit IgG (1:10000; Jackson Immunoresearch Labs, West Grove, PA). The mouse anti-adaptin γ and anti-GM130 (1:500, 1:1000, respectively, BD Biosciences, Mississauga, ON) were recognized by HRPconjugated goat anti-mouse IgG (1:2000, Jackson Immunoresearch Labs). As a control for the specificity of the SPCA2 antibody, western blots were repeated using preimmune serum or following preabsorption with purified SPCA2 antigen.
For immunohistochemistry (IHC), pancreatic tissue was isolated from WT and Mist1 −/− mice, embedded in paraffin and sectioned to 5 μm. Following deparaffinization, antigen retrieval was performed with a 20-min incubation in sodium citrate buffer (pH = 6) followed by washing in PBS, 2 × 5 min washes with 0.2% Triton X in PBS, and more washes in PBS. Endogenous HRP activity was quenched with a 5-min incubation in 3% H 2 O 2 . Sections were blocked for 30 min in 10% goat serum and incubated for 1 h at room temperature in primary antibodies diluted in blocking serum. Following PBS washes, sections were incubated in biotinylated secondary antibodies diluted in blocking serum for 30 min at room temperature, washed and then incubated for 30 min at room temperature in ABC complex, prepared as described by manufacturer (Pierce, Rockford, IL). HRP was detected with a diaminobenzidine staining kit (Pierce, Rockford, IL) and then sections were washed counterstained with hematoxylin. For immunofluorescence (IF), pancreata were processed as described [10] . Primary antibodies used included rabbit anti-SPCA2 ( 
In situ hybridization
In situ hybridization was performed on 7 μm cryosections as described [13] . Digoxigenin-labelled RNA probes were synthesized by in vitro transcription of region-spanning parts of the insulin and amylase coding regions from pancreatic cDNA and the Atp2c2 clone (#4984604) (for primer sequences, see Table S1 ) using T3 RNA polymerase. Staining was visualized using OpenLab 4.0.3 Modular Software for Scientific Imaging.
Construct design and cloning
To generate FLAG-tagged, C-terminal SPCA2 expression vector, primers were designed to amplify exons 24 to 27 of the Atp2c2 gene (Table S1 ). FLAG-Spca2 760-944 was amplified from pCMV-SPORT6-3'Spca2 plasmid (clone # 4984604) and ligated into the pSC-A vector using the Strataclone™ PCR Cloning kit (Stratagene, La Jolla, CA). pSC-A-FLAG-Spca2 760-944 was digested with XbaI and
BamHI and ligated into pcDNA3.0(+) (cut with the same enzymes) using the Roche Rapid DNA ligation kit and transformed into DH5α Escherichia coli competent cells (Invitrogen).
Cell culture and transfection
All cell culture reagents were purchased from Gibco (Burlington, ON) unless otherwise stated. Primary cell cultures were established as 
Results
Loss of MIST1 results in altered Ca 2+ movement and decreased regulated exocytosis in pancreatic acinar cells [5] (Supplemental Fig. S1 ). Analysis of individual proteins involved in Ca 2+ movement within the cell revealed a decrease in IP 3 R3 accumulation but no change in the protein levels of the SERCA or PMCA pumps in isolated acini [5, 15] . The maintained expression of the ATPases in other models [16, 17] , so a compensatory increase in the SERCA and PMCA pumps would not be surprising. The only exception to the compensation mechanism was the Atp2c2 gene where transcripts were readily detected in all WT pancreatic samples but were absent in Mist1 −/− pancreata (Fig. 1A) . The decrease in Atp2c2 expression was confirmed by qRT-PCR (Fig. 1B) , Northern blot ( Fig. 1C ) and in situ hybridization analyses ( Fig. 1D-I ) where Atp2c2 transcripts were exclusively restricted to acinar cells (Fig. 1D) . To further examine SPCA2, which is the protein encoded by the Atp2c2 gene, we generated an antibody specific for its C-terminal region. Western blots of protein extracts from HEK 293T cells transfected with expression vectors for a truncated FLAG-tagged SPCA2 (FLAG-SPCA2 760-944 ), HA-tagged MIST1 or control GFP protein identified the expected 20 kDa band corresponding to the truncated FLAG-SPCA2 760-944 protein ( Fig. 2A) . Similarly, the SPCA2 antibody recognized a protein in the acinar cell line AR42J, but not in ARIP cells which are MIST1 negative [2] . Surprisingly, the protein size in AR42J cells was only slightly larger than the truncated FLAG-SPCA2 760-944 protein. This protein was not observed following Western blot analysis after preabsorption with a SPCA2 blocking peptide (Fig. 2D) or with preimmune serum (Supplemental Fig. S2 ). The lower molecular weight isoform of SPCA2 was detected in whole pancreatic and brain protein samples (Fig. 2B) but not in Mist1 −/− protein extracts (Fig. 2C ), suggesting that SPCA2 in pancreatic cells is much smaller than its NCBIpredicted molecular mass. Again, preabsorption with the SPCA2 blocking peptide completely abolished detection of the 20 kDa protein even with extended exposures (Fig. 2D) . Interestingly, we did not detect the published full-length (103 kDa) SPCA2 protein in pancreatic extracts, although this larger isoform was detected in brain samples (Fig. 2B) .
In an effort to establish if the smaller pancreas SPCA2 protein was the product of degradation, we assessed the size of Atp2c2 transcripts. Northern blot analysis revealed that the pancreas produced a much smaller Atp2c2 transcript than the expected full length transcript (Fig. 1C) . Quantitative RT-PCR confirmed that transcripts encoding exons 24-27 were approximately 100-fold more abundant in pancreas and 5-fold more abundant in salivary gland samples when compared to transcripts encoding exons 15-17 (Supplemental Fig. S3 ). Importantly, this difference in amplification was not observed in RNA samples from testes, where both sets of primers amplified equivalent amounts of Atp2c2 transcripts. Together, these data suggest that an alternative size transcript of Atp2c2 exists in the pancreas whose expression is regulated by MIST1.
To date, no targeted knockout of Atp2c2 has been reported. However, ablation of the closely related Atp2c1 gene resulted in expansion of the Golgi complex and an altered ER stress response [18] . Previous studies from our group showed that Mist1 −/− acini also exhibit an altered ER stress response [12] , suggesting that pancreatic SPCA2 may play a similar role as SPCA1. To address this, we next examined the overall organization of acinar Golgi in WT and Mist1 −/− pancreata using cis (GM130) and trans (adaptin γ)
Golgi-specific markers. Immunofluorescence (IF) analysis revealed an expansion of the Golgi complexes in Mist1 −/− acini ( Fig. 3A-D) .
Western blots confirmed an increase in adaptin γ and GM130 proteins in Mist1 −/− tissue (Fig. 3E ). To determine if Golgi function was disrupted in acinar cells lacking MIST1, WT and Mist1
pancreas sections were incubated with a FITC-conjugated wheat germ agglutinin (WGA), which recognizes sialic acid and Nacetylglucosaminyl sugar residues on glycosylated proteins that are processed through the Golgi. Fluorescent imaging revealed a marked decrease in lectin accumulation in Mist1 −/− acinar cells compared to WT pancreata (Figs. 4 and S4 ). FITC-WGA primarily detects acinar cell zymogen granules and does not co-localize with the endoplasmic reticulum (Fig. 4) . The decrease in FITC-WGA binding in Mist1 −/− samples supports the idea of improper Golgi (Fig. 4E, F, G) , suggesting widespread defects in the Golgi and ER compartments of these cells.
To assess the location of SPCA2 accumulation in the pancreas, IHC analysis was performed on paraffin sections (Fig. 5) . Expression was observed throughout acinar tissue (Fig. 5A ) and in a subset of islet cells (Fig. 5B ) typically restricted to cells at the periphery of the islets. Pancreatic ducts (Fig. 5A ), intercalated ducts (Fig. 5C ) and blood vessels (Fig. 5D ) were all negative for SPCA2 accumulation. Interestingly, the loss of SPCA2 in Mist1 −/− tissue is specific to acinar cells as SPCA2+ islet cells are still observed in the islets of Mist1 −/− pancreata (Fig. 5F ). These cells are not β cells as they did not stain for insulin expression based on co-IF analysis (Fig. 5G, H) . Surprisingly, the majority of SPCA2 appeared to accumulate in the basolateral region of pancreatic acinar cells (Fig. 5) , consistent with localization to the ER. To assess intra-acinar localization (Fig. 6 ), SPCA2 accumulation was compared to markers for the Golgi apparatus (adaptin γ) and ER (calreticulin and SERCA2). Pancreatic acinar cells have a highly organized intracellular structure with the Golgi apparatus positioned between the basally localized nuclei and the apical-located zymogen granules [19] . SPCA2 accumulation (Fig. 6A ) was consistent with calreticulin ( Fig. 6D) and SERCA2 (Fig. 6E ) localization, limited to the basal portion of the acinus. Adaptin γ (Fig. 6C ) accumulated just apical to the ER. To verify that pancreas SPCA2 does not localize to the Golgi, we next performed co-IF using antibodies against SPCA2 and either GM130 or adaptin γ (Fig. 7) . In confirmation of the IHC results, SPCA2 did not colocalize with GM130 (Fig. 7A , C, E) or adaptin γ (Fig. 7B, D, F Fig. 8B-C ) and gastric glands of the stomach ( Fig. 8D-I) , exhibited a dramatic reduction in SPCA2 levels. Importantly, SPCA2 levels were not altered in the surface epithelial cells of the stomach (arrowheads in Fig. 8D , E), which never express MIST1.
To support Atp2c2 as a downstream target of MIST1, we employed a genetic mouse model in which expression of a MIST1 transgene (LSL-Mist1 endogenous Atp2c2 transcript levels, which continued to increase to WT levels over the next two days (Fig. 9) ATPase proteins have been documented in this model. In the current study, we identified a specific loss of the Ca 2+ ATPase Atp2c2/SPCA2 in Mist1 −/− pancreatic acinar cells as well as in other secretory cells that normally express MIST1, suggesting a link. While the loss of SPCA2 correlated with expansion of the Golgi compartment and disruption in protein glycosylation, the pancreatic isoform of SPCA2 does not localize to the Golgi, nor does it contain many of the domains required for Ca 2+ pump action. Therefore, we have identified a novel isoform of the Atp2c2 gene that may be, in part, responsible for the altered acinar cell phenotype observed in Mist1 −/− mice.
Unlike past studies on Ca 2+ ATPase expression, we observed increased accumulation of Atp2a (SERCA) and Atp2b (PMCA) pumps. There are two possibilities for the differences in expression. First, this study examines mRNA levels in vivo, while Luo et al (2005) examined protein levels in cultured acini. There may be differences in transcript or protein accumulation or the culturing of the cells could account for differences in expression. Second, the antibodies used by Luo et al (2005) were not specific to individual PMCA or SERCA isoforms. Since we have not performed an exhaustive study for all SERCA and PMCA isoforms, it is possible that the total levels are equal. In any event, the only Atp2 gene that is reduced in Mist1 −/− pancreatic tissue is Atp2c2. Mouse genetic studies showed that reactivation of MIST1 was closely followed by increased Atp2c2 transcript levels suggesting that Atp2c2 may be a downstream target of MIST1 transcriptional activity. Indeed, the overall expression pattern for Atp2c2 correlated predominantly with MIST1 expression. Previous studies have revealed that Atp2c2 is expressed in a number of tissues, most notably in the testes, brain and lactating mammary gland [20, 21] . While MIST1 is not found in testes or brain, it is expressed transiently in epithelial alveolar cells during lactation [20] . Similar to Atp2c2, expression of Mist1 decreases to negligible levels upon mammary gland involution [22, 23] . Our studies have now extended the expression pattern of SPCA2 to include the secretory cells of pancreatic acini, salivary gland acini, seminal vesicles and stomach epithelium. In all cases, Atp2c2/SPCA2 expression correlates with MIST1 expression. Importantly, loss of MIST1 in these tissues produced dramatically decreased levels of Atp2c2 and this expression pattern could be rescued in the pancreas within hours by inducing concentrations are required for accurate post-translational modifications [7] . The SPCA proteins are the mammalian equivalent to the PMR1 protein found in yeast and defective glycosylation and an altered secretory pathway are observed in Pmr1-deficient yeast, a phenotype similar to that found in Mist1 −/− acini [24] [25] [26] . In addition, targeted ablation of the closely related mouse Atp2c1 gene results in expansion of the Golgi compartment consistent with that observed in Mist1 −/− acini [27] . It is interesting that a similar phenotype is observed in Mist1 −/− tissue without a decrease in Atp2c1 expression levels. While a model with MIST1 affecting exocrine cell function through the regulation of Atp2c2 is attractive, we have uncovered novel findings regarding the structure and localization of the SPCA2 protein that adds considerable complexity. IF analysis indicated that SPCA2 does not co-localize with GM130 or adaptin γ at the Golgi apparatus. Instead, we show for the first time that SPCA2 localizes in the same location as the ER in both pancreas and salivary gland acinar cells. In agreement with our current observations, studies examining SPCA2 in neuronal cells also found that SPCA2 localizes to cellular regions outside of the Golgi apparatus [21] . Interestingly, localization of SPCA2 to the ER is more consistent with a role for this protein in regulated exocytosis. The Ca 2+ required for exocytosis is contained within the ER of acinar cells, and during physiological stimulation, Ca 2+ oscillations are observed within the apical portion of the acinar cells [28] , suggesting that rapid release and uptake from the ER is essential for efficient transport of digestive enzymes out of the cell. Even more intriguing is that our studies have uncovered a previously unknown pancreatic SPCA2 isoform that is significantly smaller (17) (18) (19) (20) than the NCBI predicted SPCA2 protein (103 kDa). While it is possible that this protein represents a degradation product, our data support the existence of an alternative SPCA2 protein. First, immunoabsorption with the peptide used to generate the antibody eliminates the 20 kDa band observed in pancreatic protein extracts. Second, the 17-20 kDa SPCA2 band is detected in protein extracts from WT We have attempted to identify the complete sequence of this novel Atp2c2 transcript through 5′ RACE, degenerate primers, or mass spectrometry of protein extracts resolved by twodimensional gel electrophoresis. However, to date, most of our success stems from bioinformatic analysis of EST databases. ACEview suggests that 4 transcripts for Atp2c2 exist, but none of these transcripts correlate to the size of mRNA observed in the pancreas. Based on ACEview, 75 ESTs exist with sequences identical to the Atp2c2 gene. Eight of these ESTs were derived from pancreatic tissue, all aligned to the 3' end of the gene. Not one of these ESTs would produce an alternative transcript that corresponds to the predicted molecular weight of the protein, which is in the range of 17 to 22 kDa. The largest pancreatic EST is AK007419, which was derived from a tiling array of cDNA from 10-day-old mouse pancreatic tissue. The EST is 704 bps and, when translated, produces a 104 amino acid protein that aligns with the carboxy terminus of the protein. All other pancreatic ESTs are less than 400 bp in length. There is a single EST identified that would produce a protein the size of the predicted pancreatic SPCA2 isoform. Accession #BI414588 was cloned from pooled lung tissue and is 935 bp long. It encodes exons 20-26 and translation from the first identified Kozak sequence would produce, in frame, a 185 amino acid protein. Further studies are necessary to determine if this represents the full length protein found in the pancreas.
In conclusion, we have identified a novel protein that is identical to the carboxy terminus of SPCA2. While lacking the functional domains required for Ca 
Methodology
Isolated acini were stimulated with 0.1 pM to 10 nM CCK. Cells were stimulated for 30 min, and centrifuged at 3000 rpm for 12 sec to obtain the supernatant. At the beginning and end of the stimulation period, an aliquot of non-stimulated cells was prepared in a similar fashion for control secretion levels. 100 l of the control supernatants was removed and taken as the level of background amylase release (O T ). The cells in the control aliquot were sonicated and used to determine total amylase content (T T ). All concentrations were performed in duplicate.
Amylase in the supernatant (X) was determined as described in Kowalik et al (2007) . The percent amylase released was determined by dividing the amount of amylase released after stimulation for 30 min by the total amount of amylase within the cells and subtracting the background levels from the amount released [(X-O T )/T T ]. 
